BEDFORD, Mass. — GenesisM, a joint venture between Bain Capital Real Estate and Botanic Properties, has officially broken ground on a 154,000-square-foot Class A biomanufacturing facility at 45 Crosby Drive in Bedford. The groundbreaking ceremony brought together project stakeholders, local officials, and representatives from the biotech and real estate communities.
The new facility aims to address growing demand for specialized life sciences manufacturing space in the Greater Boston area. Designed with flexibility and efficiency in mind, the facility will feature GenesisM’s proprietary Enhanced Core platform, which reduces tenant build-out time and capital expenditures, aligning manufacturing capabilities with the evolving needs of life science companies.
Strategically located along the Route 3 corridor, the site offers close proximity to Kendall Square and the region’s dense biotech ecosystem. The facility is being built to support multiple tenants, each with access to independent, highly regulated manufacturing suites and dedicated infrastructure.
“This groundbreaking marks a major milestone in the evolution of GenesisM,” said Joshua Zinns, Managing Principal of Botanic Properties. “We are proud to advance our mission of delivering flexible, capital-efficient biomanufacturing facilities that help companies bring innovative therapies to market faster and more efficiently. We are particularly pleased to be able to deliver this project in Bedford, MA, which is one of the most forward-thinking communities for life science and technology companies.”
Key features of the facility include 27-foot ceiling heights, 18 loading berths, 12,000 amps of power, and 40-by-40-foot column spacing—elements intended to maximize operational flexibility and scalability.
Construction is now underway, with core and shell completion expected in Q3 2026. Tenant fit-outs could begin as early as Q2 2026. The project team includes Commodore Builders as construction manager; Perkins&Will as design architect; BR+A Consulting Engineers for MEP; Thornton Tomasetti for structural engineering; VHB as civil engineer; and Arcadis providing cGMP peer review.
Financing for the development is being provided by Barings, a global real estate investment manager.
“The entire GenesisM team would like to show our appreciation to Barings,” Zinns said during the ceremony. “Barings has been studying and dedicating resources to the biomanufacturing sector for years, which allowed them to make an informed investment decision when the right project came along.”
